Huntington's Disease and Mitochondria

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by striatal neuronal loss.
• Clinical symptoms include motor dysfunction, cognitive decline, and psychiatric disturbances.
• HD is caused by expanded CAG repeats in the huntingtin gene, leading to mutant huntingtin (mHtt) protein.

Purpose of the Study:

• To review evidence supporting the hypothesis that mHtt causes mitochondrial dysfunction in HD.
• To explore the association between huntingtin protein (Htt) and mitochondria in normal conditions.
• To understand how mHtt impacts cellular signaling, mitochondrial biogenesis, and ATP levels in HD.

Main Methods:

• Literature review of recent findings on HD, mHtt, and mitochondrial function.
• Analysis of cellular and molecular mechanisms underlying HD pathogenesis.
• Focus on the role of mitochondria in neuronal energy metabolism and survival.

Main Results:

• Mutant huntingtin (mHtt) accumulation is linked to mitochondrial defects, including impaired ATP generation and increased reactive oxygen species (ROS).
• mHtt disrupts mitochondrial trafficking, maintenance, integrity, function, dynamics, and hemostasis.
• mHtt affects cellular signaling pathways that regulate mitochondrial biogenesis, potentially leading to reduced ATP levels.

Conclusions:

• Mitochondrial dysfunction is a key contributor to neuronal degeneration in Huntington's disease.
• mHtt directly impacts mitochondrial health and function, making neurons vulnerable.
• Understanding the interplay between mHtt and mitochondria offers potential therapeutic targets for HD.